|
Medical Advocates/ADAP FUND New and Noteworthy |
||
|
|
May 16,
2008 Featured
Report Clinical Management Update Drug
Update Diagnostic/Monitoring
Updates Marginalized
Update US
Update Global
Update![]() ![]() ![]() |
|
|
This web page is best viewed by using INTERNET EXPLORER |
| Today's Featured Report |
|
| Disease Management Update |
|
SMART study. Strategies for Management of Antiretroviral Therapy (SMART) Study Group. Journal Abstract HAART |
| Drug Update |
|
Efficacy and Safety of 48 Weeks of Enfuvirtide 180 mg Once-Daily Dosing
Versus 90 mg Twice-Daily Dosing in HIV-Infected Patients. Wright D, Rodriguez A, Godofsky E, et al HIV Clin Trials. 2008 Mar-Apr;9(2):73-82 Journal Abstract Enfuvirtide |
| Diagnostic/Monitoring Update |
|
Chan DJ, McNally L. Curr HIV Res. 2008 May;6(3):182-8. Journal Abstract |
| Marginalized Update | |
|
vertically infected infants. Palma P, Romiti ML, Cancrini C, et al Vaccine. 2008 Apr 15 Journal Abstract Children |
|
| US Update | |
|
Asghar RJ, Pratt RH, Kammerer JS, Navin TR. Arch Intern Med. 2008 May 12;168(9):936-42. Journal Abstract US Updates |
|
| Global Update | |
|
Tornesello ML, Duraturo ML, Giorgi-Rossi P, et al J Gen Virol. 2008 Jun;89(Pt 6):1380-1389. Journal Abstract |
|
| Week-in-Review | |
|
the week of May 05-12, 2008 May 12, 2008 |
|
|
|
|
NEW AND NOTEWORTHY |
|
The New and Noteworthy Web
features a daily interdisciplinary focus on current journal, conference, |
|
This web site is supported in
part with an unrestricted educational grant from |